Sign In
Buy CLOV
$3.65
-0.0800 (-2.14%)
At Close: Jun 03, 2026
Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026. Disciplined, core-market growth, strong
Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost
08:30am, Monday, 12'th Jan 2026
SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Counterpart Health , Inc. (“Counterpart” or the “Company”), a leading AI-powered physician-enablement platform and subsidiary of Clover Health
Clover Health Investments, Corp. (NASDAQ:CLOV) Given Consensus Rating of “Hold” by Analysts
03:20am, Sunday, 11'th Jan 2026
Clover Health Investments, Corp. (NASDAQ: CLOV - Get Free Report) has earned an average recommendation of "Hold" from the five analysts that are currently covering the stock, Marketbeat reports. One i
Here's Why You Should Retain CLOV Stock in Your Portfolio Now
09:31am, Thursday, 18'th Dec 2025
Clover Health shows strong membership growth, rising revenues and sustained EBITDA gains from Clover Assistant, though near-term margin pressure remains a risk.
Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference
04:05pm, Tuesday, 16'th Dec 2025
WILMINGTON, Del., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive O
Clover Health Investments, Corp. (CLOV) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
05:28pm, Thursday, 04'th Dec 2025
Clover Health Investments, Corp. (CLOV) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Why Is Clover Health Investments (CLOV) Down 11.6% Since Last Earnings Report?
12:37pm, Thursday, 04'th Dec 2025
Clover Health Investments (CLOV) reported earnings 30 days ago. What's next for the stock?
Clover Health: Smart Money Should Be Accumulating Ahead Of 2026 GAAP Profits
08:47pm, Sunday, 30'th Nov 2025
Despite disappointing YTD earnings due to higher than expected medical costs, Clover's expected GAAP profitability in 2026 marks a critical inflection point. Clover's higher returning member mix and t
Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference
04:05pm, Monday, 17'th Nov 2025
WILMINGTON, Del., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial O
Head-To-Head Review: Hims & Hers Health (NYSE:HIMS) vs. Clover Health Investments (NASDAQ:CLOV)
05:03am, Monday, 17'th Nov 2025
Clover Health Investments (NASDAQ: CLOV - Get Free Report) and Hims and Hers Health (NYSE: HIMS - Get Free Report) are both medical companies, but which is the better investment? We will contrast the
Clover Health Investments, Corp. (CLOV) Presents at UBS Global Healthcare Conference 2025 Transcript
02:21pm, Tuesday, 11'th Nov 2025
Clover Health Investments, Corp. ( CLOV ) UBS Global Healthcare Conference 2025 November 11, 2025 11:00 AM EST Company Participants Peter Kuipers - Chief Financial Officer Presentation Unknown Analyst
Why Fast-paced Mover Clover Health Investments (CLOV) Is a Great Choice for Value Investors
09:56am, Thursday, 06'th Nov 2025
Clover Health Investments (CLOV) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the seve
CLOV Q3 Earnings Miss, Stock Falls on Raised Insurance BER View
12:06pm, Wednesday, 05'th Nov 2025
Clover Health's Q3 sales soar 50%, but higher Insurance costs and a raised BER outlook weigh on investor sentiment.
Teacher Retirement System of Texas Grows Stock Position in Clover Health Investments, Corp. $CLOV
03:45am, Wednesday, 05'th Nov 2025
Teacher Retirement System of Texas boosted its stake in shares of Clover Health Investments, Corp. (NASDAQ: CLOV) by 4.5% during the undefined quarter, according to its most recent 13F filing with the
Clover Health Investments, Corp. (CLOV) Q3 2025 Earnings Call Transcript
10:06pm, Tuesday, 04'th Nov 2025
Clover Health Investments, Corp. ( CLOV ) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Ryan Schmidt - Investor Relations Analyst Andrew Toy - Co-Founder, CEO & Director Pete
